Jocelyn Solis-Moreira

Jocelyn Solis-Moreira

Feature Writer

MSc Psychology, Concentration in Behavioral Neuroscience, BSc Integrative Neuroscience, Minor in Education

Jocelyn Solis-Moreira graduated with a Bachelor's in Integrative Neuroscience, where she then pursued graduate research looking at the long-term effects of adolescent binge drinking on the brain's neurochemistry in adulthood. She is adept at translating and summarizing complex study findings in all medical fields with a particular interest in neurodegenerative diseases, cancer research, infectious diseases, and public health. As a freelance writer, her work spans from news articles and feature articles to evergreen explainers across many publications. Her overall goal is to make science accessible for all.

Articles from Jocelyn

Preclinical study finds sex differences in neurological response to SARS-CoV-2 infection

Preclinical study finds sex differences in neurological response to SARS-CoV-2 infection

Study identifies most persistent neurological problems during long COVID-19

Study identifies most persistent neurological problems during long COVID-19

SARS-CoV-2 main protease conformations are temperature-dependent

SARS-CoV-2 main protease conformations are temperature-dependent

Human organoids useful for modeling COVID-19 variants of concern, finds study

Human organoids useful for modeling COVID-19 variants of concern, finds study

SARS-CoV-2 infection prolongs viral shedding and lymphocyte loss in patients with cancer

SARS-CoV-2 infection prolongs viral shedding and lymphocyte loss in patients with cancer

Researchers develop a multivalent vaccine for COVID-19 and influenza

Researchers develop a multivalent vaccine for COVID-19 and influenza

Study finds no evidence of increased risk for COVID-19 from aspirin/NSAID use

Study finds no evidence of increased risk for COVID-19 from aspirin/NSAID use

Can the absence of evidence of in-school SARS-CoV-2 transmission be taken as evidence of absence?

Can the absence of evidence of in-school SARS-CoV-2 transmission be taken as evidence of absence?

A new SARS-CoV-2 variant (HMN.19B) has been identified in France

A new SARS-CoV-2 variant (HMN.19B) has been identified in France

Vaccine candidate targeting SARS-CoV-2 nucleocapsid protein elicits protective immune response in animal model

Vaccine candidate targeting SARS-CoV-2 nucleocapsid protein elicits protective immune response in animal model